Cathelicidin (LL-37) vs Protegrin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
LL-37 is the sole human cathelicidin antimicrobial peptide, derived by proteolytic cleavage of the 18 kDa precursor hCAP18 (encoded by the CAMP gene). It is produced by neutrophils, epithelial cells of the skin, gut, and airways, and mast cells....
Calculate Cathelicidin (LL-37) dose →Protegrins are disulfide-bridged beta-hairpin antimicrobial peptides isolated from porcine leukocytes. Protegrin-1 (PG-1) is one of the most potent AMPs against both Gram-positive and Gram-negative bacteria, including multidrug-resistant organisms....
Calculate Protegrin dose →| Parameter | Cathelicidin (LL-37) | Protegrin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Clinical Research | Phase III (failed) |
| Half-Life | < 10 min (plasma) | Hours (disulfide stabilized) |
| Typical Dose | Research: 1-100 ug/mL (topical) | N/A |
| Frequency | Varies by application | N/A |
| Route | Endogenous; topical/inhalation (research) | Topical / Rinse |
| FDA Status | No approval (clinical trials ongoing) | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.